Skip to content
DraconiticResearch
Search Sources API
186,086 studies31 sourcesUpdated 42 min ago
Peer-reviewedCC BYThe World Allergy Organization journal

Adverse health outcomes and patient and physician perspectives of attenuated androgen use in hereditary angioedema☆

6 affiliations
  1. 1Institute of Allergology, Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
  2. 2Centro Universitario Faculdade de Medicina ABC, Santo André, SP, Brazil
  3. 3Curta Inc, Seattle, WA, USA
  4. 4BioCryst, Durham, NC, USA
  5. 5Department of Clinical and Environmental Allergology, Jagiellonian University Medical College, Krakow, Poland
  6. 6Royal Free London NHS Foundation Trust, London, UK

Related

  1. Experiences From the First Year of Using Garadacimab to Treat Hereditary Angioedema and Acquired Angioedema
    Markus Magerl, Kathrin Schön, Janine Ruhe +3
    Clinical and translational allergyPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Long-term prophylaxis for hereditary angioedema: Navigating the switch between therapies☆
    Aleena Banerji, Jonathan A. Bernstein, Laurence Bouillet +11
    The World Allergy Organization journalPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  3. Hereditary Angioedema with Normal C1-Inhibitor in Children: Diagnostic Challenges, Novel Mutations in MYOF, F12, and HS3ST6, and the Role of Bioinformatics Analysis
    Anita R. Denisova, Natalia G. Kolosova, Natalia A. Geppe +7
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Human geneticsCrossref
  4. Periprocedural management of patients with hereditary angioedema undergoing coronary angiography and percutaneous coronary intervention
    Michał Tarnowski, Paulina Brania, Iwona Gorczyca-Głowacka +1
    Postepy w kardiologii interwencyjnej = Advances in interventional cardiologyPeer-reviewedCC BY-NC-SAFull textHuman geneticsEurope PMCPMC
  5. Garadacimab in Hereditary Angioedema: Modeling Suggests Sustained Improvements in Attack-Free Probability and Quality of Life Over 5 Years.
    Philip H Li, F Ida Hsu, Emel Aygören-Pürsün +7
    Clinical and translational sciencePeer-reviewedCC BY-NCFull textHuman geneticsEurope PMC
BibTeX
@article{magerl2026adverse,
  title = {{Adverse health outcomes and patient and physician perspectives of attenuated androgen use in hereditary angioedema☆}},
  author = {Markus Magerl and Anete S. Grumach and Noemi Fluetsch Brennan and Adam Gordois and Maria Pedrosa and Nikolina Boskovic and Lisa Bloudek and Sandra Nestler-Parr and Patrick Gillard and Marcin Stobiecki and Sorena Kiani-Alikhan},
  journal = {The World Allergy Organization journal},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13675641},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Adverse health outcomes and patient and physician perspectives of attenuated androgen use in hereditary angioedema☆
AU  - Markus Magerl
AU  - Anete S. Grumach
AU  - Noemi Fluetsch Brennan
AU  - Adam Gordois
AU  - Maria Pedrosa
AU  - Nikolina Boskovic
AU  - Lisa Bloudek
AU  - Sandra Nestler-Parr
AU  - Patrick Gillard
AU  - Marcin Stobiecki
AU  - Sorena Kiani-Alikhan
PY  - 2026
DA  - 2026/09/22
JO  - The World Allergy Organization journal
UR  - https://europepmc.org/article/PMC/PMC13675641
SN  - 1939-4551
ER  -